Dr. Rachel Joy Gordon, MD

Dr. Gordon practices at Columbia University Irving Medical Center in New York, New York.

Dr. Gordon's NPI, 1235183070, was assigned on May 19, 2006. Dr. Gordon graduated from Vanderbilt University School Of Medicine in 2000. Dr. Gordon holds New York license 222335.

Dr. Gordon's primary practice is Columbia University Irving Medical Center, at 622 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 297-4255.

Dr. Gordon's primary practice is Columbia University Irving Medical Center in New York, New York. Dr. Gordon is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Gordon to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gordon practices. Vendor and product names are available with a free account.

Infectious disease is Dr. Gordon's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Gordon is board certified in infectious disease by the American Board of Internal Medicine. Dr. Gordon is licensed in New York.

Dmand AI lists sepsis among the conditions Dr. Gordon treats.

CMS data shows 68 Medicare services from Dr. Gordon across 2 procedure codes in 2024, for 47 Medicare patients. Medicare paid $8,333 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 47 Medicare patients who saw Dr. Gordon in 2024. The largest group is 65 to 74, with 24 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 53% are also on Medicaid. Their average risk score is 3.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gordon's median patient age at 64, with 48% women.

In 2024, Dr. Gordon wrote 33 Medicare Part D claims. 82% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $103 in total drug cost. In 2019, CMS named 25 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Gordon for performance year 2024, reported through an alternative payment model (APM). Dr. Gordon accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 24 papers to Dr. Gordon, published from 2005 to 2023. 2021 was the busiest year, with 3. The most frequent topics are Staphylococcal Infections, Staphylococcus aureus and Anti-Bacterial Agents. Dr. Gordon has published most often in AIDS Behav. Dr. Gordon's most frequent co-authors are Rachel Gordon, Franklin David Lowy, MD and Isaac George, MD.

Dmand AI links Dr. Gordon to 1 clinical trial. Conditions studied include Staphylococcal Infections and Gram-Positive Bacterial Infections.

CMS Open Payments shows 4 general payments to Dr. Gordon from 4 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $77.

Dmand AI lists 5 awards for Dr. Gordon, most recently Distinguished Teacher of the Year in 2019.

Dr. Gordon graduated from Vanderbilt University School Of Medicine in 2000. Dr. Gordon is a member of IDSA.

Dr. Gordon is in network with 12 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.